LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Canertinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4047 | 4156 | 0.9739 | 0.9629 |
MCF7 | Celastrol | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4494 | 4156 | 1.0814 | 1.1159 |
MCF7 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4211 | 4156 | 1.0132 | 1.0188 |
MCF7 | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 604 | 4156 | 0.1453 | -0.2162 |
MCF7 | CHIR-99021 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3565 | 4156 | 0.8578 | 0.7977 |
MCF7 | CP724714 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3247 | 4156 | 0.7813 | 0.6887 |
MCF7 | CP466722 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4851 | 4156 | 1.1672 | 1.2379 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3325 | 4156 | 0.8002 | 0.7157 |
MCF7 | Momelotinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3936 | 4156 | 0.9472 | 0.9249 |
MCF7 | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2621 | 4156 | 0.6307 | 0.4745 |
MCF7 | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1127 | 4156 | 0.2712 | -0.0370 |
MCF7 | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3846 | 4156 | 0.9255 | 0.8939 |
MCF7 | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4036 | 4156 | 0.9713 | 0.9591 |
MCF7 | Erlotinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 3468 | 4156 | 0.8345 | 0.7645 |
MCF7 | Foretinib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4219 | 4156 | 1.0151 | 1.0215 |
MCF7 | R406 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4106 | 4156 | 0.9881 | 0.9831 |
MCF7 | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1727 | 4156 | 0.4157 | 0.1685 |
MCF7 | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4620 | 4156 | 1.1117 | 1.1589 |
MCF7 | Geldanamycin | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2274 | 4156 | 0.5473 | 0.3558 |
MCF7 | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2465 | 4156 | 0.5933 | 0.4212 |
MCF7 | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4288 | 4156 | 1.0319 | 1.0454 |
MCF7 | GSK1059615 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4166 | 4156 | 1.0024 | 1.0034 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1953 | 4156 | 0.4699 | 0.2457 |
MCF7 | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1362 | 4156 | 0.3278 | 0.0435 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2655 | 4156 | 0.6388 | 0.4860 |